Evidence map›Paper›PMID 37579846›Full record

ArticleVirus research2023

The neuropathological mechanism of EV-A71 infection attributes to inflammatory pryoptosis and viral replication via activating the hsa_circ_0045431/ hsa_miR_584/NLRP3 regulatory axis.

Yajie Hu, Yue Yu, Ruian Yang, Ruibing Wang, Dandan Pu, Yujue Wang, Jingyuan Fan, Yunhui Zhang, Jie Song

Open access · goldAbstract read
In one paragraph

Article in Virus research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yajie HuDepartment of Respiratory Medicine, The First People's Hospital of Yunnan Province, Kunming, PR China; The Affiliated Hospital of Kunming University of Science and Technology, Kunming, PR China.
Yue YuInstitute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, PR China.
Ruian YangDepartment of Respiratory Medicine, The First People's Hospital of Yunnan Province, Kunming, PR China; The Affiliated Hospital of Kunming University of Science and Technology, Kunming, PR China.
Ruibing WangDepartment of Respiratory Medicine, The First People's Hospital of Yunnan Province, Kunming, PR China; The Affiliated Hospital of Kunming University of Science and Technology, Kunming, PR China.
Dandan PuDepartment of Respiratory Medicine, The First People's Hospital of Yunnan Province, Kunming, PR China; The Affiliated Hospital of Kunming University of Science and Technology, Kunming, PR China.
Yujue WangDepartment of Respiratory Medicine, The First People's Hospital of Yunnan Province, Kunming, PR China; The Affiliated Hospital of Kunming University of Science and Technology, Kunming, PR China.
Jingyuan FanDepartment of Respiratory Medicine, The First People's Hospital of Yunnan Province, Kunming, PR China; The Affiliated Hospital of Kunming University of Science and Technology, Kunming, PR China.
Yunhui ZhangDepartment of Respiratory Medicine, The First People's Hospital of Yunnan Province, Kunming, PR China; The Affiliated Hospital of Kunming University of Science and Technology, Kunming, PR China. Electronic address: zhangyh123kh@163.com.
Jie SongInstitute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, PR China. Electronic address: songjiekm@163.com.
First People's Hospital of Yunnan Province · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNKunming University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuropathological damage has been considered to be the main cause of death from EV-A71 infection, but the underlying mechanism has not been elucidated. Pyroptosis, a new form of inflammatory programmed cell death, has been verified to be involved in the pathogenesis of various viruses. circRNAs are a novel type of endogenous noncoding RNA gaining research interest in recent years, especially their special roles in the process of virus infection. Thus, in this study, we combined EV-A71, pyroptosis and circRNA to find a breakthrough in the pathogenesis of EV-A71 infection. Firstly, whether EV-A71 infection leaded to pyroptosis formation was examined by a series detection of cell death, cell viability, LDH release, caspase 1 activity, the expression levels of pyroptosis-related molecules and the concentrations of IL-1β and IL-18. Secondly, high-throughput sequencing of circRNAs was carried out to excavate the circRNA-miRNA-mRNA regulatory axis which might be associated with pyroptosis formation. Finally, the gain- and loss-of-functional experiments were further conducted to identify their functions. Our results showed that EV-A71 infection caused pyroptosis formation in SH-SY5Y cells. The circRNA sequencing analyzed the differentially expressed circRNAs and their possible functions. It was found that the hsa_circ_0045431/hsa_miR_584/NLRP3 regulatory axis might be involved in pyroptosis formation during EV-A71 infection. Then, hsa_circ_0045431 sponged hsa_miR_584 and hsa_miR_584 directly targeted NLRP3 were validated by IF, dual-luciferase, qRT-PCR and WB assays. Functional experiments were performed to further uncover that the up-regulation of hsa_circ_0045431 and NLRP3 promoted the inflammatory pyroptosis and viral replication, while the up-regulation of hsa_miR_584 suppressed the inflammatory pyroptosis and viral replication, and vice versa. Collectively, our study demystified that EV-A71 infection induced pyroptosis formation by activating hsa_circ_0045431/hsa_miR_584/NLRP3 regulatory axis, which could further effect viral replication. These findings provided novel insights into the pathogenesis of EV-A71 infection, and meanwhile revealed that the hsa_circ_0045431/ hsa_miR_584/NLRP3 regulatory axis can serve as a potential biological therapeutic target for EV-A71 infection.

Indexed as

Enterovirus A, HumanMicroRNAsNeuroblastomaHumansNLR Family, Pyrin Domain-Containing 3 ProteinRNA, CircularVirus ReplicationMicroRNAsMIRN584 microRNA, humanNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanRNA, CircularCircRNAEnterovirus A71 (EV-A71)NLRP3Pyroptosis

Identifiers

PMID37579846
PMCPMC10450994
OpenAlexW4385827629

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.